Portal Biotechnologies Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $10.5M

  • Investors
  • 11

Portal Biotechnologies General Information

Description

Developer of a cell-engineering platform designed to support cell-based research, therapeutic development, and biological data generation. The company offers proprietary mechanoporation technology for delivering RNA, proteins, gene-editing tools, and small molecules into primary cells while preserving cell viability and function, enabling pharmaceutical companies, academic hospitals, and cancer research centers to advance drug discovery, cell engineering, and precision medicine research.

Contact Information

Website
www.portal.bio
Formerly Known As
Repro-T Company
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 134 Coolidge Avenue
  • Watertown, MA 02472
  • United States
+1 (508)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • 134 Coolidge Avenue
  • Watertown, MA 02472
  • United States
+1 (508)

Portal Biotechnologies Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Portal Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 29-May-2026 $10.5M Completed Generating Revenue
2. Seed Round 20-Dec-2024 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Portal Biotechnologies’s complete valuation and funding history, request access »

Portal Biotechnologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-6
Seed-5
Seed-4
Seed-3
Seed-2
Seed-1 2,152,971 $0.000117 $0.67 $0.67 1x $0.67 2.91%
Seed 4,320,167 $0.000117 $0.58 $0.58 1x $0.58 5.83%
To view Portal Biotechnologies’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Portal Biotechnologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cell-engineering platform designed to support cell-based research, therapeutic development, and biologica
Discovery Tools (Healthcare)
Watertown, MA
25 As of 2026

Rockville, MD
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Portal Biotechnologies Competitors (5)

One of Portal Biotechnologies’s 5 competitors is MaxCyte, a Formerly VC-backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MaxCyte Formerly VC-backed Rockville, MD
Synthego Venture Capital-Backed Redwood City, CA
AVECTAS Venture Capital-Backed Kildare, Ireland
Thermo Fisher Scientific Formerly PE-Backed Waltham, MA
Lonza Bioscience Corporation Colmar, France
You’re viewing 5 of 5 competitors. Get the full list »

Portal Biotechnologies Patents

Portal Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026207215-A1 Cellular interaction assays involving delivery of one or more components by mechanoporation Pending 26-Mar-2025
US-D1154964-S1 Cell mechanoporation cartridge Active 07-May-2024
US-D1111186-S1 Tabletop cell mechanoporation system Active 07-May-2024
WO-2025128569-A1 Cell mechanoporation cartridges and methods of use thereof Inactive 11-Dec-2023
EP-4823755-A1 High-throughput systems for intracellular delivery and components and uses thereof Pending 11-Dec-2023 B01D63/087
To view Portal Biotechnologies’s complete patent history, request access »

Portal Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Portal Biotechnologies Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
NFX Venture Capital Minority
TechU Ventures Venture Capital Minority
10X Capital Venture Capital Minority
Conscience Venture Capital Minority
IA Ventures Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Portal Biotechnologies FAQs

  • When was Portal Biotechnologies founded?

    Portal Biotechnologies was founded in 2023.

  • Where is Portal Biotechnologies headquartered?

    Portal Biotechnologies is headquartered in Watertown, MA.

  • What is the size of Portal Biotechnologies?

    Portal Biotechnologies has 25 total employees.

  • What industry is Portal Biotechnologies in?

    Portal Biotechnologies’s primary industry is Discovery Tools (Healthcare).

  • Is Portal Biotechnologies a private or public company?

    Portal Biotechnologies is a Private company.

  • What is the current valuation of Portal Biotechnologies?

    The current valuation of Portal Biotechnologies is .

  • What is Portal Biotechnologies’s current revenue?

    The current revenue for Portal Biotechnologies is .

  • How much funding has Portal Biotechnologies raised over time?

    Portal Biotechnologies has raised $22.8M.

  • Who are Portal Biotechnologies’s investors?

    NFX, TechU Ventures, 10X Capital, Conscience, and IA Ventures are 5 of 11 investors who have invested in Portal Biotechnologies.

  • Who are Portal Biotechnologies’s competitors?

    MaxCyte, Synthego, AVECTAS, Thermo Fisher Scientific, and Lonza Bioscience are competitors of Portal Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process